Study Compares Enteral and Parenteral Nutrition in Brain-Injured Patients

  • PubMed
  • May 27, 2025
  • 0 Comments

A prospective randomized clinical trial investigated the effectiveness of total parenteral nutrition (TPN) versus enteral nutrition (EN) in patients with brain injuries characterized by Glasgow Coma Scale (GCS) scores between 4 and 10 at admission. The study included 51 patients who were monitored from the time of hospital admission through 18 days post-injury.

Participants were randomly assigned to receive either TPN or EN, both critical approaches to providing nutritional support in patients unable to feed orally. TPN involves delivering nutrients intravenously, bypassing the gastrointestinal tract, while EN provides nutrition through a tube placed in the stomach or small intestine.

The primary outcome was assessed using the Glasgow Outcome Scale, a standardized tool to evaluate functional recovery in brain-injured individuals. The study aimed to determine which method of nutritional support contributed more effectively to patient recovery and overall outcomes.

Initial findings suggested that the method of nutritional delivery may have a significant impact on the recovery trajectory in patients with moderate to severe traumatic brain injury. Further analysis of the data will be necessary to determine long-term implications and to guide future clinical practice in neurocritical care settings.

These results contribute to the growing body of evidence on optimal supportive care for critically injured patients and underscore the importance of personalized nutrition therapy in neurorehabilitation strategies.

Source: https:// – Courtesy of the original publisher.

  • Related Posts

    Study Highlights Role of Astrocytes in Glioblastoma’s Therapeutic Resistance

    Glioblastoma, the most common and aggressive type of primary brain cancer, remains notoriously difficult to treat, with current therapies offering limited success. A new study brings attention to a key…

    Study Identifies Serotonin Transporter as Novel Immune Checkpoint in Cancer

    In a significant advancement in cancer immunology, scientists have identified the serotonin transporter (SERT) as a novel immune checkpoint that could hinder antitumor T cell responses. This finding opens the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    West Johnston High and Triangle Math and Science Academy Compete in Brain Game Playoff

    • May 10, 2025
    West Johnston High and Triangle Math and Science Academy Compete in Brain Game Playoff

    New Study Reveals ‘Ice Piracy’ Phenomenon Accelerating Glacier Loss in West Antarctica

    • May 10, 2025
    New Study Reveals ‘Ice Piracy’ Phenomenon Accelerating Glacier Loss in West Antarctica

    New Study Suggests Certain Chemicals Disrupt Circadian Rhythm Like Caffeine

    • May 10, 2025
    New Study Suggests Certain Chemicals Disrupt Circadian Rhythm Like Caffeine

    Hospitalization Rates for Infants Under 8 Months Drop Significantly, Data Shows

    • May 10, 2025
    Hospitalization Rates for Infants Under 8 Months Drop Significantly, Data Shows

    Fleet Science Center Alters Anniversary Celebrations After Losing Grant Funding

    • May 10, 2025
    Fleet Science Center Alters Anniversary Celebrations After Losing Grant Funding

    How Microwaves Actually Work: A Scientific Breakdown

    • May 10, 2025
    How Microwaves Actually Work: A Scientific Breakdown